These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11369710)

  • 1. Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining.
    Derby MA; Wang J; Margulies DH; Berzofsky JA
    Int Immunol; 2001 Jun; 13(6):817-24. PubMed ID: 11369710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
    Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
    J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
    Choi EM; Chen JL; Wooldridge L; Salio M; Lissina A; Lissin N; Hermans IF; Silk JD; Mirza F; Palmowski MJ; Dunbar PR; Jakobsen BK; Sewell AK; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5116-23. PubMed ID: 14607910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.
    Alexander MA; Damico CA; Wieties KM; Hansen TH; Connolly JM
    J Exp Med; 1991 Apr; 173(4):849-58. PubMed ID: 1901079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
    Chung DH; Belyakov IM; Derby MA; Wang J; Boyd LF; Berzofsky JA; Margulies DH
    J Immunol; 2001 Jul; 167(2):699-707. PubMed ID: 11441073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.
    Drake DR; Ream RM; Lawrence CW; Braciale TJ
    J Immunol; 2005 Aug; 175(3):1507-15. PubMed ID: 16034088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
    Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
    Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
    Hornell TM; Myers N; Hansen TH; Connolly JM
    J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
    J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
    Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM
    J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity.
    Sandberg JK; Franksson L; Sundbäck J; Michaelsson J; Petersson M; Achour A; Wallin RP; Sherman NE; Bergman T; Jörnvall H; Hunt DF; Kiessling R; Kärre K
    J Immunol; 2000 Jul; 165(1):25-33. PubMed ID: 10861031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
    Kessler BM; Bassanini P; Cerottini JC; Luescher IF
    J Exp Med; 1997 Feb; 185(4):629-40. PubMed ID: 9034142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRβ clonotype.
    Moffat JM; Handel A; Doherty PC; Turner SJ; Thomas PG; La Gruta NL
    J Immunol; 2010 Dec; 185(11):6850-6. PubMed ID: 21041725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity.
    Dorothée G; Vergnon I; El Hage F; Le Maux Chansac B; Ferrand V; Lécluse Y; Opolon P; Chouaib S; Bismuth G; Mami-Chouaib F
    J Immunol; 2005 Jun; 174(11):6888-97. PubMed ID: 15905531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral peptide specific cytotoxic T lymphocytes are of high avidity to host-MHC but only low avidity to donor-MHC after allogeneic bone marrow transplantation.
    Kyburz D; Speiser DE
    Transpl Immunol; 1995 Jun; 3(2):143-50. PubMed ID: 7582905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
    Belyakov IM; Kozlowski S; Mage M; Ahlers JD; Boyd LF; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Dec; 19(12):1413-20. PubMed ID: 17981793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR.
    Lawson TM; Man S; Wang EC; Williams S; Amos N; Gillespie GM; Moss PA; Borysiewicz LK
    Int Immunol; 2001 Nov; 13(11):1383-90. PubMed ID: 11675370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.